Methylprednisolone aceponate
Advantan ointment contains the active substance methylprednisolone aceponate, which is a corticosteroid with strong effects, for topical use. After topical application to the skin, methylprednisolone aceponate has anti-inflammatory, anti-itching, and vasoconstrictive effects, causing the disappearance of symptoms such as redness, swelling, exudation, itching, burning, and pain.
Eczema (atopic dermatitis, neurodermatitis), contact dermatitis, intertrigo, non-allergic eczema, eczema in children.
Do not use in children under 2 years of age.
The medicine, especially in children, should be used in the smallest possible dose for the shortest possible time.
If the doctor finds that a bacterial or fungal skin infection has occurred, they will also use antibacterial or antifungal treatment.
Local use of the medicine may exacerbate local skin infections.
Avoid contact of the medicine with the eyes, open wounds, and mucous membranes.
When using the medicine on the skin of the face, be cautious and do not use an occlusive dressing. Using the medicine on the skin of the face may lead to skin atrophy more often than when using it on other areas of the body.
If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.
If there have been cases of glaucoma in the past, inform the doctor before using Advantan ointment. Similarly, as with systemic corticosteroids, during treatment with Advantan ointment, there is a risk of developing glaucoma (e.g., when using large doses of the medicine or using it on large areas of skin or for a long time, as well as after applying the medicine under an occlusive dressing or on the skin close to the eyes).
Using the medicine on large areas of skin should be for the shortest possible time.
Using the medicine on damaged skin, in skin folds, on large areas of skin, for a long time, or under an occlusive dressing significantly increases the risk of systemic side effects characteristic of corticosteroids.
Avoid using an occlusive dressing. In children, diapers can act as an occlusive dressing. Conditions similar to those after using occlusive dressings also occur in intertriginous areas of the body (armpits, groin, skin folds, skin between the fingers).
Do not use in children under 2 years of age.
In children over 2 years of age, use the medicine with caution - in the smallest possible doses for the shortest possible time. Do not use an occlusive dressing.
There are no reports of interactions between Advantan ointment and other medicines.
Tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
Do not use the medicine during the first trimester of pregnancy.
Your doctor may recommend using the medicine in pregnant women and breastfeeding mothers after carefully assessing the risk-benefit ratio.
Breastfeeding women should not use Advantan ointment on the breast skin.
Avoid using the medicine on large areas of skin, for a long time, or under an occlusive dressing.
Advantan ointment does not affect the ability to drive or operate machines.
Always use this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
Advantan ointment is for topical use on the skin only.
Usually, the medicine is applied in a thin layer to the affected skin once a day.
Do not use the medicine in adults for more than 12 weeks.
Do not use in children under 2 years of age.
In children over 2 years of age, do not use for more than 4 weeks.
If you feel that the effect of Advantan ointment is too strong or too weak, consult your doctor.
There is no risk of acute poisoning after a single overdose of the medicine on the skin (using a large area of skin in conditions of increased absorption) or after accidental ingestion of the medicine.
If you miss a dose of the medicine at the scheduled time, use it as soon as possible.
Do not use a double dose to make up for the missed dose.
If the patient experiences a recurrence of the original disease symptoms after completing treatment, they should contact their doctor.
If you have any further doubts about using the medicine, consult your doctor or pharmacist.
Like all medicines, Advantan ointment can cause side effects, although not everybody gets them.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
The most commonly observed side effects during clinical trials were folliculitis at the application site and burning at the application site.
Common (affects 1 to 10 people in 100):folliculitis at the application site, burning at the application site.
Uncommon (affects 1 to 10 people in 1000):pustules at the application site, blisters at the application site, itching at the application site, pain at the application site, redness at the application site, nodules at the application site, skin cracks, superficial vessel dilatation (telangiectasia).
Frequency not known (cannot be estimated from the available data):hypersensitivity reactions to the medicine, excessive hair growth, acne, skin thinning (atrophy), skin stretch marks, perioral dermatitis, skin discoloration, skin hypersensitivity reactions, blurred vision).
During topical use of products containing corticosteroids, systemic symptoms may occur due to their absorption through the skin.
If you experience any side effects, including any side effects not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
Store in a temperature below 25°C, in the original packaging.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
White to yellowish transparent ointment.
Packaging: aluminum tube internally coated with epoxy resin, with a protective membrane and an HDPE screw cap, containing 50 g of ointment, placed in a cardboard box.
For more detailed information, please contact the marketing authorization holder or the parallel importer.
LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup, Denmark
LEO Pharma Manufacturing Italy S.r.l.
Via E. Schering 21
20090 Segrate (Milan), Italy
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorization number in Romania, the country of export:11639/2019/05
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.